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Abstract: For regenerative purposes, there is a high de-
mand for viable and active cells. A big issue is to have
enough viable cells available at any given time. One solu-
tion is cryopreservation. In this context, DMSO is used as
cryoprotective agent (CPA) along with fetal bovine serum
for nutrient supply and stress shielding effects. To use
these cells for human clinical studies, it is important to
eliminate the serum to prevent foreign immune reactions
and virus transmittance and DMSO for its toxic effect.
In this study a serum free cryopreservation solution and
protocol has been established. The combination ofmethyl-
cellulose and poloxamer 188 provide the basis for the
new CPA. Other additves are α-tocopherol, ectoine, prolin
and ascorbic acid. The CPAs were examined with 3T3-cells
andmultipotent stromal cells from the commonmarmoset
monkey (Callithrix jacchus). The cells were preserved with
various CPA concentrations, incubation times and differ-
ent cooling rates. To enable a higher throughput of en-
couraging conditions a fluorescence microscopy analysis
was used. The use of methylcellulose, poloxamer 188 and
α-tocopherol enables the reduction of DMSO [up to 2.5%
(v/v)] and the elimination of serumwithout viability losses
compared to control.
Keywords: antioxidants; cryopreservation; fluorescence
microscopy; methylcellulose; multipotent stromal cells;
poloxamer 188; serum free.
1 Introduction
The cryopreservation of human cells opens new options
for medical therapies. The physicians get new opportuni-
ties to cure their patients with new methods.
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The cells are stored at temperatures below −150°C.
The metabolic activity stops at these temperatures [1].
The biggest issue is to ensure the viability and the
functionality of the cells after thawing. The use of cryopro-
tective agents (CPA) reduces the required cooling rate and
enhances the cryopreservation outcome. The most com-
mon used CPA is a combination of 5–10% (v/v) dimethyl-
sulfoxid (DMSO) and up to 90% (v/v) foetal bovine serum
(FBS) in combination with a cooling rate of 1 K/min [1].
DMSO is toxic in high concentrations [e.g. 10% (v/v)] and
cause denaturation of cells’ proteins [2–4] and leads to
differentiation of stem cells.
FBS is an undefined mixture of proteins and growth
factors that nourishes the cells. Moreover the high pro-
tein content stabilizes and protects the membrane against
shear stresses [5].
For clinical applications it is important to eliminate
the animal serum to prevent immune responses. Further-
more FBS is an undefined substance which has different
concentrations in every charge [6–8].
This study shows that there is a possibility to eliminate
the FBS and reduce the concentration of DMSO with the
usage of alternative CPAs.
2 Material and methods
2.1 Material
Unless otherwise stated, chemicals were purchased from
Sigma Aldrich (Germany).
2.2 Cell lines
Thepre-testswereconductedwith3T3-cells.Tovalidate the
results,bonemarrowmultipotentstromalcells (MSC)of the
commonmarmosetmonkey (Callithitix jacchus)wereused.
2.3 Cultivation of 3T3-cells and MSCs
3T3-cells were cultured in 75-cm2 flasks with Dulbecco’s
Modified Eagle’s Medium (DMEM, Merck Millipore,
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Table 1: Additives of the basic cell freezing solution.
Name Pro (mm) E (mm) AA (µm) α-toc (µm) FBS [% (v/v)]
A – – – – –
B 10 100 – – –
C 10 100 500 – –
D – – – 200 –
Control – – – – 15 (3T3)
22.5 (MSC)
Germany) with 10% (v/v) FBS and 1% (v/v) Penicillin /
Streptomycin (Pen / Strep; Biochrome, Germany). MSCs
were cultured in a 160 mm2 culture dish using a culture
medium (MSC-medium) containing DMEM, 15% (v/v)
FBS, 1% (v/v) Pen / Strep and 50 µm ascorbic acid (AA).
Cells were cultured under 37°C and 5% CO2 in a humified
incubator (Binder GmbH, Germany) until 85% confluence.
2.4 Serumfree CPAs
The potential CPAs were based on 0.1% (v/v) methylcellu-
lose (M) (4000 cP) and 1% (v/v) poloxamer 188 (P). Addi-
tional compunds were proline (Pro, Carl Roth, Germany),
ectoine (E; Biomol, Germany), AAand α-tocopherol (α-toc)
in the concentrations shown in Table 1.
2.5 Cryopreservation
The samples were frozen in 0.2 ml PCR strips (Carl Roth,
Germany). For freezing, two different freezing devices (WB
230 Askion C-Line® and CM-2000 Air Products GmbH,
Germany) were used. For 3T3-cells a cell-concentration of
2 × 105 and for MSCs of 106 cells were used per sample.
The control-solution for 3T3-cells was composed of DMEM
mixed up with 10% (v/v) DMSO and 15% (v/v) FBS. The
cooling rate was 1 K/min. The MSC freezing medium con-
sisted of DMEM with 5% (v/v) DMSO and 22.5% (v/v) FBS.
MSCswere frozenwith a cooling rate of 7.5 K/min to−30°C
followed by 3 K/min to−80°C [9].
Cells were frozen using either 1 or 5 K/min (3T3) and
the abovementioned cooling rate forMSCs. Both cell types
were frozen using different parameters (DMSO concen-
trations for 3T3: 0–5%/MSCs: up to 2.5%) and different
incubation times (10, 30 and 60 min). No FBS was added
in groups except for controls.
Cells were stored at −150°C for at least 24 h and then
thawed and analysed. For thawing, the PCR strips were
swivelled in a 37°C water bath until only a small clump
of ice was visible. Afterwards they were centrifuged in a
centrifuge (Biozym Scientific, Germany) with 6000 rpm
for 10 s, supernatant removed, re-suspended in culture
medium and transferred to a 12-well plate and cultured for
24 h at 37°C.
2.6 Fluorescence microscopy
After incubation, the cells were washed and then fixed
with 4% paraformaldehyd for 10 min. Thereafter the cell
nuclei were stained with the fluorescence dye Hoechst
33,342 for 1 h. To count the cells in a sector of everywell, 36
pictures of the centre of each well were taken with the flu-
orescence microscopy Axiovert 200 (Carl Zeiss, Germany).
Images were analysed with ImageJ (Fiji, open source).
2.7 Re-cultivation rates
To determine the efficiency of re-cultivation after thawing,
only MSCs were used.
Onemilliliter, containing 106 cells, were frozen in 2 ml
cryovials (Biochrome, Germany) using the above men-
tioned CPAs.
After thawing, the cells were transferred into falcon
tubes (Sarstedt, Germany) and centrifuged at 4°C and 900
rpm for 8 min.
After removing the supernatant, the cells were re-
suspended in 1 ml MSC-medium and cultured for 24 h at
37°C.
After incubation, the cells were detachedwith Trypsin
EDTA (PAA, Germany) and counted by an automatic cell-
counter ViCell™ XR (Beckmann Coulter GmbH, Germany)
by Trypan blue dye exclusion. Efficiency of re-cultivation
is represented by the ratio of total number of adherent
cells to initial number of cells during seeding and was
considered as cell viability after cryopreservation.
3 Results
3.1 Cryopreservation
At first, the new process for low volume cryopreservation
was examined and validated. With this setup, it was pos-
sible to get a high throughput with several parameters like
cooling rates, incubation time or different concentrations
of DMSO for each run.
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Figure 1: Cryopreservation outcomes of 3T3 with a cooling rate of
1 K/min and a incubation time of 10 min.
3.1.1 3T3
The investigations showed, that the most promising re-
sults were achieved while using 1 K/min, no FBS and
10 min incubation time (Figure 1).
As it is shown, the base solution (M, P) with addition
of 5% (v/v) DMSO, yields nearly the same cell count as
the control with 10% (v/v) DMSO and FBS. The highest
amount of viable cells was yielded by the basis solution
with addition of α-toc and 2.5% (v/v) DMSO. Moreover
all other solutions delivered similar results compared to
the control. All the cell counts were in the range between
11,000 and 13,000 cells per well-sector.
3.1.2 MSC
Afterwards, the results were validated by using MSCs.
Figure 2 shows an extract of these outcomes. A comparison
between the two used cooling rates are shown. Further-
more different incubations times were used (number in
brackets).
The highest cell count was found while using the
standard cooling rate (7.5 K/min to −30°C and 3 K/min
to −80°C) and the basis solution (M, P) with addition of
Pro, E, AA and 2.5% (v/v) DMSO. There is no significant
different between this condition and the control which
contented 5% (v/v) DMSO and 22.5% (v/v) FBS.
Thehighest cell countwith the cooling rate of 1 K/min,
which is the most important for the common laboratories,
was delivered by the use of the basis solution, α-toc and
2.5% (v/v) DMSO. There was also no significance in the
deviation of cell count in comparison with the control.
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Figure 2: Survival of MSCs after cryopreservation using different
cooling rates and incubation times. The number in brackets are the
used incubation time.
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Figure 3: Re-cultivation rates of cryopreserved MSCs. Comparison
between two cooling rates.
3.2 Re-cultivation rates
Finally the previous results were confirmed by investigat-
ing the efficiency of re-cultivation for the best results of the
MSC studies. The results are shown in Figure 3.
No significant differences were found for all groups
except M, P, E and AA.
There are some differences in comparison with the re-
sults from above (3.1.2.). Even though no differences were
found, the CPA with α-toc seems the best choice for the
serum free cryopreservation of stem cells.
4 Conclusion
In standard freezing protocol FBS is used in different con-
centrations (5–95%) but for clinical applications animal
derived undefined substances are forbidden.
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This study shows that it is possible to reduce theDMSO
concentration and completely exclude serum. This should
be the foundation to preserve human stem cells with this
new CPA. But it is important to further investigate if the
CPA protects not only the viability but also the functional-
ity of cells.
Furthermore the process, to investigate cell numbers
after cryopreservationbyfluorescencemicroscopy enables
a higher quantity of trials in shorter time, which also
means lower costs. If the results could be validated with
a small amount of additional studies, it would be a low
cost method to improve the cryopreservation protocol for
regenerative approaches.
Complementing methods could be the use of con-
trolled induced ice formation. With different nucleation
temperatures it is might be possible to preserve the cells
without toxic substances like DMSO.
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